In the Phase II clinical trial, mechanically ventilated intensive care patients, who are at particular high risk of acquiring severe and often life-threatening forms of Pseudomonas aeruginosa infections,
Ms Sofer was appointed in December 2005 to lead Yissum. She joined Yissum from the venture capital industry where she held a series of senior roles in Israel
The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia. miRview meso differentiates mesothelioma, a cancer connected to asbestos exposure, from other carcinomas in the
iCAD said that it has received CE Mark approval to market and sell its customized solution with Agfa HealthCare’s computed radiography systems and units have been placed at
Potential trade names are still under review with the FDA. Following issuance of a trade name, Ferring Pharmaceuticals, USA is expected to immediately begin commercialization in the US. Previously, the
The option period ends on March 31, 2009. Terms of the option stipulate that the primary use of SemBioSys’s plant-produced insulin would be for Afresa, MannKind’s insulin, which
According to the company, TPI 1020 showed overall safety and tolerability, although its activity profile was not significantly different from budesonide, a conventional corticosteroid commonly used in respiratory
ALN-VSP contains two small interfering RNAs (siRNAs), the molecules that mediate RNAi, formulated in a lipid nanoparticle developed by Tekmira Pharmaceuticals. The proposed Phase I study is a
The letter was received following the company’s Class 1 resubmission in response to an October 2008 complete response letter. The company believes that no additional clinical trials will
The marketing authorization was granted by the European Commission for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation with: Intermediate-2 and high-risk
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.